Venus Remedies secures marketing authorization from UK MHRA for Cisplatin
Company intends to increase sales in the UK to approximately 2 million Euros by focusing on seven molecules which are already registered in the country
Company intends to increase sales in the UK to approximately 2 million Euros by focusing on seven molecules which are already registered in the country
SVB Financial Group and its subsidiaries were involved in over $1.4 billion in total venture financing raised from 2010 to 2022 for drug development
Department of Biotechnology is going to play an important part in the integrated holistic healthcare approach against elimination of Tuberculosis
With the combination of oral solid, inhalation, dermatology, high potent and oral contraceptive products, this is an important facility of the company
The product will be manufactured at the plant of Bell, Sons & Co. (Druggists) Ltd. located at Gifford House, Slaidburn Crescent, Southport, UK
Surana is a chartered accountant with an all-India rank.
EZHARMIA is the fifth innovative oncology medicine to be launched in Japan by Daiichi Sankyo in the past three years
Aster DM Healthcare and Faruk Medical City will jointly provide training and academic support to medical and paramedical staff
Proceeds from the transaction will be reinvested towards the growth, innovation and expansion of Healthium’s advanced surgery, orthopaedics, wound care and post-surgical care portfolio
The virtual event will be attended by representatives from state & district health administration, corporates, industries, civil society, and NGOs as the country reiterates its commitment towards TB elimination by 2025
Subscribe To Our Newsletter & Stay Updated